WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003074557) NOVEL B−CELL MALIGNANCY−ASSOCIATED PROTEIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/074557    International Application No.:    PCT/GB2003/000910
Publication Date: 12.09.2003 International Filing Date: 06.03.2003
IPC:
C07K 14/47 (2006.01)
Applicants: OXFORD GLYCOSCIENCES (UK) LTD [GB/GB]; Attn: Mary Gadsden, The Forum, 86 Milton Park, Abingdon, Oxfordshire OX14 4RY (GB) (For All Designated States Except US).
ADAM, Paul, J [GB/GB]; (GB) (For US Only).
LOADER, Julie, Ann [GB/GB]; (GB) (For US Only).
TERRETT, Jonathan, Alexander [GB/GB]; (GB) (For US Only)
Inventors: ADAM, Paul, J; (GB).
LOADER, Julie, Ann; (GB).
TERRETT, Jonathan, Alexander; (GB)
Agent: BLAKEY, Alison, Jane; Oxford GlycoSciences (UK) Ltd, The Forum, 86 Milton Park, Abingdon, Oxfordshire OX14 4RY (GB)
Priority Data:
0205257.9 06.03.2002 GB
0229682.0 19.12.2002 GB
Title (EN) NOVEL B−CELL MALIGNANCY−ASSOCIATED PROTEIN
(FR) NOUVELLE PROTEINE ASSOCIÉE À LA MALIGNITÉ DE LYMPHOCYTE B
Abstract: front page image
(EN)The present invention provides a novel protein (BCNP−1) compositions comprising the protein, vaccines and antibodies that are immunospecific for the protein. The use of the protein in the diagnosis, screening, treatment and prophylaxis of B−cell malignancies, in particular Chronic Lymphocytic Leukaemia (CLL) is also provided.
(FR)La présente invention a trait à des compositions d'une nouvelle protéine (BNCP-1) comportant la protéine, des vaccins et des anticorps qui sont immunospécifiques de la protéine. L'invention a trait également à l'utilisation de la protéine dans le diagnostic, le dépistage, le traitement et la prophylaxie de malignités de lymphocyte B, notamment la leucémie lymphoïde chronique (LLC).
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)